Literature DB >> 20817278

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

James A Duce1, Andrew Tsatsanis, Michael A Cater, Simon A James, Elysia Robb, Krutika Wikhe, Su Ling Leong, Keyla Perez, Timothy Johanssen, Mark A Greenough, Hyun-Hee Cho, Denise Galatis, Robert D Moir, Colin L Masters, Catriona McLean, Rudolph E Tanzi, Roberto Cappai, Kevin J Barnham, Giuseppe D Ciccotosto, Jack T Rogers, Ashley I Bush.   

Abstract

Alzheimer's Disease (AD) is complicated by pro-oxidant intraneuronal Fe(2+) elevation as well as extracellular Zn(2+) accumulation within amyloid plaque. We found that the AD β-amyloid protein precursor (APP) possesses ferroxidase activity mediated by a conserved H-ferritin-like active site, which is inhibited specifically by Zn(2+). Like ceruloplasmin, APP catalytically oxidizes Fe(2+), loads Fe(3+) into transferrin, and has a major interaction with ferroportin in HEK293T cells (that lack ceruloplasmin) and in human cortical tissue. Ablation of APP in HEK293T cells and primary neurons induces marked iron retention, whereas increasing APP695 promotes iron export. Unlike normal mice, APP(-/-) mice are vulnerable to dietary iron exposure, which causes Fe(2+) accumulation and oxidative stress in cortical neurons. Paralleling iron accumulation, APP ferroxidase activity in AD postmortem neocortex is inhibited by endogenous Zn(2+), which we demonstrate can originate from Zn(2+)-laden amyloid aggregates and correlates with Aβ burden. Abnormal exchange of cortical zinc may link amyloid pathology with neuronal iron accumulation in AD.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817278      PMCID: PMC2943017          DOI: 10.1016/j.cell.2010.08.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  63 in total

1.  Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

Authors:  Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John Harrison; Colin L Masters; Steve Targum; Ashley I Bush; Ross Murdoch; Janet Wilson; Craig W Ritchie
Journal:  Lancet Neurol       Date:  2008-07-30       Impact factor: 44.182

2.  Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts.

Authors:  D M Lawson; P J Artymiuk; S J Yewdall; J M Smith; J C Livingstone; A Treffry; A Luzzago; S Levi; P Arosio; G Cesareni
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

3.  Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein.

Authors:  J Rossjohn; R Cappai; S C Feil; A Henry; W J McKinstry; D Galatis; L Hesse; G Multhaup; K Beyreuther; C L Masters; M W Parker
Journal:  Nat Struct Biol       Date:  1999-04

4.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.

Authors:  Nadine El Tannir El Tayara; Benoît Delatour; Camille Le Cudennec; Maryvonne Guégan; Andreas Volk; Marc Dhenain
Journal:  Neurobiol Dis       Date:  2005-12-07       Impact factor: 5.996

5.  Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice.

Authors:  Suh Young Jeong; Samuel David
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

6.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains.

Authors:  S W Suh; K B Jensen; M S Jensen; D S Silva; P J Kesslak; G Danscher; C J Frederickson
Journal:  Brain Res       Date:  2000-01-10       Impact factor: 3.252

7.  Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.

Authors:  K Furukawa; B L Sopher; R E Rydel; J G Begley; D G Pham; G M Martin; M Fox; M P Mattson
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

8.  Redox active iron accumulation in aceruloplasminemia.

Authors:  Luis F Gonzalez-Cuyar; George Perry; Hiroaki Miyajima; Craig S Atwood; Marcela Riveros-Angel; Patrick F Lyons; Sandra L Siedlak; Mark A Smith; Rudy J Castellani
Journal:  Neuropathology       Date:  2008-02-15       Impact factor: 1.906

9.  Iron incorporation into apoferritin. The role of apoferritin as a ferroxidase.

Authors:  G R Bakker; R F Boyer
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

10.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  226 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  The neurophysiology and pathology of brain zinc.

Authors:  Stefano L Sensi; Pierre Paoletti; Jae-Young Koh; Elias Aizenman; Ashley I Bush; Michal Hershfinkel
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 3.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

4.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

5.  CD1 Mouse Retina Is Shielded From Iron Overload Caused by a High Iron Diet.

Authors:  Devang L Bhoiwala; Ying Song; Alyssa Cwanger; Esther Clark; Liang-liang Zhao; Chenguang Wang; Yafeng Li; Delu Song; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

6.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

Authors:  Peng Lei; Scott Ayton; David I Finkelstein; Loredana Spoerri; Giuseppe D Ciccotosto; David K Wright; Bruce X W Wong; Paul A Adlard; Robert A Cherny; Linh Q Lam; Blaine R Roberts; Irene Volitakis; Gary F Egan; Catriona A McLean; Roberto Cappai; James A Duce; Ashley I Bush
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

Review 7.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

8.  Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.

Authors:  Anne Suttkus; Susanne Rohn; Carsten Jäger; Thomas Arendt; Markus Morawski
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

9.  Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux.

Authors:  Adrienne C Dlouhy; Danielle K Bailey; Brittany L Steimle; Haley V Parker; Daniel J Kosman
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 10.  Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.

Authors:  Jia-Rui Wu; Qing-Zhang Tuo; Peng Lei
Journal:  J Mol Neurosci       Date:  2018-08-25       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.